In contrast, cGMP/PKG mitigates the injurious effects of repeated cardiac sympathetic activation, precluding the hypertrophy and fibrosis engendered by NA and angiotensin II (AngII, a central component of the renin-angiotensin-aldosterone system, which is also upregulated in HF) [32, 33]. This evidence concerns the gene AGT and hydrops fetalis.